Immunization with a dicistronic plasmid expressing a truncated form of bovine herpesvirus-1 glycoprotein D and the amino-terminal subunit of glycoprotein B results in reduced gB-specific immune responses

Virology

Volumn 313, Issue 1, 2003, Pages 296-307

  Manoj, Sharmila ^a,b   Babiuk, Lorne A ^a   Van Drunen Littel Van Den Hurk, Sylvia ^b  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

^b UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

Bovine herpesvirus 1; Dicistronic plasmid; DNA vaccine; Glycoprotein B; Glycoprotein D

Indexed keywords

DNA VACCINE; GLYCOPROTEIN B; GLYCOPROTEIN D;

ANIMAL CELL; ANTIGEN EXPRESSION; ANTIGEN PRESENTING CELL; ARTICLE; BOVINE HERPES VIRUS; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG EFFICACY; GENE GUN; IMMUNE RESPONSE; IMMUNIZATION; INJECTION; MOUSE; NONHUMAN; OBSERVATION; PLASMID; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; TERMINAL SEQUENCE;

BOVINAE; BOVINE HERPESVIRUS 1; HERPESVIRIDAE;

EID: 0041887435     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0042-6822(03)00325-8     Document Type: Article

References (45)

1. Braun R., Babiuk L.A., van Drunen Littel-van den Hurk S. Enhanced immune response to an intradermally delivered DNA vaccine expressing a secreted form of BHV-1 gD. Vaccine Res. 6:1997;151-164.
2. Braun R., Babiuk L.A., van Drunen Littel-van den Hurk H. Compatibility of plasmids expressing different antigens in a single DNA vaccine formulation. J. Gen. Virol. 79:1998;2965-2970.
3. Campadelli-Fiume G., Cocchi F., Menotti L., Lopez M. The novel receptors that mediate the entry of herpes simplex viruses and animal alphaherpesviruses into cells. Rev. Med. Virol. 10:2000;305-319.
4. Chase C.C., Lohff C., Letchworth G.J. 3rd. Resistance and susceptibility of bovine cells expressing herpesviral glycoprotein D homologs to herpesviral infections. Virology. 194:1993;365-369.
5. Chen H., Kim J., Kendall D.A. Competition between functional signal peptides demonstrates variation in affinity for the secretion pathway. J. Bacteriol. 178:1996;6658-6664.
6. Cotten M., Baker A., Saltik M., Wagner E., Buschle M. Lipopolysaccharide is a frequent contaminant of plasmid DNA preparations and can be toxic to primary human cells in the presence of adenovirus. Gene Ther. 1:1994;239-246.
7. Deck R.R., DeWitt C.M., Donnelly J.J., Liu M.A., Ulmer J.B. Characterization of humoral immune responses induced by an influenza hemagglutinin DNA vaccine. Vaccine. 15:1997;71-78.
8. Donnelly J.J., Ulmer J.B., Shiver J.W., Liu M.A. DNA vaccines. Annu. Rev. Immunol. 15:1997;617-648.
9. Fitzpatrick D.R., Redmond M.J., Attah-Poku S.K., van Drunen Littel-van den Hurk S., Babiuk L.A., Zamb T.J. Mapping of 10 epitopes on bovine herpesvirus type 1 glycoproteins gI and gIII. Virology. 176:1990;145-157.
10. Galliciotti G., Schneider H., Wyder L., Vitaliti A., Wittmer M., Ajmo M., Klemenz R. Signal-sequence trap in mammalian and yeast cells a comparison . J. Membr. Biol. 183:2001;175-182.
11. Gao Y., Leary T.P., Eskra L., Splitter G.A. Truncated bovine herpesvirus-1 glycoprotein I (gpI) initiates a protective local immune response in its natural host. Vaccine. 12:1994;145-152.
12. Gao Y., Wang C., Splitter G.A. Mapping T and B lymphocyte epitopes of bovine herpesvirus-1 glycoprotein B. J. Gen. Virol. 80:1999;2699-2704.
13. Ghattas I.R., Sanes J.R., Majors J.E. The encephalomyocarditis virus internal ribosome entry site allows efficient coexpression of two genes from a recombinant provirus in cultured cells and in embryos. Mol. Cell. Biol. 11:1991;5848-5859.
14. Grifantini R., Finco O., Bartolini E., Draghi M., Del Giudice G., Kocken C., Thomas A., Abrignani S., Grandi G. Multi-plasmid DNA vaccination avoids antigenic competition and enhances immunogenicity of a poorly immunogenic plasmid. Eur. J. Immunol. 28:1998;1225-1232.
15. Guan J., Ma L., Wei L. Characteristics of ovarian cancer cells transduced by the bicistronic retroviral vector containing GM-CSF and HSV-TK genes. Chin. Med. J. (Engl.). 114:2001;147-151.
16. Hughes G., Babiuk L.A., van Drunen Littel-van den Hurk S. Functional and topographical analyses of epitopes on bovine herpesvirus type 1 glycoprotein IV. Arch. Virol. 103:1988;47-60.
17. Kedl R.M., Rees W.A., Hildeman D.A., Schaefer B., Mitchell T., Kappler J., Marrack P. T cells compete for access to antigen-bearing antigen-presenting cells. J. Exp. Med. 192:2000;1105-1113.
18. Kirchhoff S., Koster M., Wirth M., Schaper F., Gossen M., Bujard H., Hauser H. Identification of mammalian cell clones exhibiting highly regulated expression from inducible promoters. Trends Genet. 11:1995;219-220.
19. Kumamoto C.A. Molecular chaperones and protein translocation across the Escherichia coli inner membrane. Mol. Microbiol. 5:1991;19-22.
20. Kumamoto C.A., Beckwith J. Evidence for specificity at an early step in protein export in Escherichia coli. J. Bacteriol. 163:1985;267-274.
21. Kwissa M., Unsinger J., Schirmbeck R., Hauser H., Reimann J. Polyvalent DNA vaccines with bidirectional promoters. J. Mol. Med. 78:2000;495-506.
22. Kyte J., Doolittle R.F. A simple method for displaying the hydropathic character of a protein. J. Mol. Biol. 157:1982;105-132.
23. Lewis P.J., van Drunen Littel-van den Hurk S., Babiuk L.A. Development of immune responses in the presence of passive antibody. J. Gen. Virol. 80:1999;2829-2837.
24. Li Y., Liang X., van Drunen Littel-van den Hurk S., Attah-Poku S., Babiuk L.A. Glycoprotein Bb, the N-terminal subunit of bovine herpesvirus 1 gB, can bind to heparan sulfate on the surfaces of Madin-Darby bovine kidney cells. J. Virol. 70:1996;2032-2037.
25. Li Y., van Drunen Littel-van den Hurk S., Liang X., Babiuk L.A. Production and characterization of bovine herpesvirus 1 glycoprotein B ectodomain derivatives in an hsp70A gene promoter-based expression system. Arch. Virol. 141:1996;2019-2029.
26. Liacopoulos P., Ben-Efraim S. Antigenic competition. Prog. Allergy. 18:1975;97-204.
27. Loehr B.I., Pontarollo R., Rankin R., Latimer L., Willson P., Babiuk L.A., van Drunen Littel-van den Hurk S. Priming by DNA immunization augments T-cell responses induced by modified live bovine herpesvirus vaccine. J. Gen. Virol. 82:2001;3035-3043.
28. Mizuguchi H., Xu Z., Ishii-Watabe A., Uchida E., Hayakawa T. IRES-dependent second gene expression is significantly lower than cap-dependent first gene expression in a bicistronic vector. Mol. Ther. 1:2000;376-382.
29. Musacchio A., Rodriguez E.G., Herrera A.M., Quintana D., Muzio V. Multivalent DNA-based immunization against hepatitis B virus with plasmids encoding surface and core antigens. Biochem. Biophys. Res. Commun. 282:2001;442-446.
30. O'Hagan D., Singh M., Ugozzoli M., Wild C., Barnett S., Chen M., Schaefer M., Doe B., Otten G.R., Ulmer J.B. Induction of potent immune responses by cationic microparticles with adsorbed human immunodeficiency virus DNA vaccines. J. Virol. 75:2001;9037-9043.
31. Pancholi P., Liu Q., Tricoche N., Zhang P., Perkus M.E., Prince A.M. DNA prime-canarypox boost with polycistronic hepatitis C virus (HCV) genes generates potent immune responses to HCV structural and nonstructural proteins. J. Infect. Dis. 182:2000;18-27.
32. Rhodes G.H., Abai A.M., Margalith M., Kuwahara-Rundell A., Morrow J., Parker S.E., Dwarki V.J. Characterization of humoral immunity after DNA injection. Dev. Biol. Stand. 82:1994;229-236.
33. Ros C., Belak S. Characterization of the glycoprotein B gene from ruminant alphaherpesviruses. Virus Genes. 24:2002;99-105.
34. Rusch S.L., Chen H., Izard J.W., Kendall D.A. Signal peptide hydrophobicity is finely tailored for function. J. Cell. Biochem. 55:1994;209-217.
35. Schneider S.C., Sercarz E.E. Antigen processing differences among APC. Hum. Immunol. 54:1997;148-158.
36. Sharma S., Wang J., Huang M., Paul R.W., Lee P., McBride W.H., Economou J.S., Roth M.D., Kiertscher S.M., Dubinett S.M. Interleukin-7 gene transfer in non-small-cell lung cancer decreases tumor proliferation, modifies cell surface molecule expression, and enhances antitumor reactivity. Cancer Gene Ther. 3:1996;302-313.
37. Staal F.J., Bakker A.Q., Verkuijlen M., van Oort E., Spits H. Use of bicistronic retroviral vectors encoding the LacZ gene together with a gene of interest a method to select producer cells and follow transduced target cells . Cancer Gene Ther. 3:1996;345-351.
38. Tikoo S.K., Campos M., Babiuk L.A. Bovine herpesvirus 1 (BHV-1): biology, pathogenesis, and control. Adv. Virus Res. 45:1995;191-223.
39. van Drunen Littel-van den Hurk S., Braun R.P., Lewis P.J., Karvonen B.C., Baca-Estrada M.E., Snider M., McCartney D., Watts T., Babiuk L.A. Intradermal immunization with a bovine herpesvirus-1 DNA vaccine induces protective immunity in cattle. J. Gen. Virol. 79:1998;831-839.
40. van Drunen Littel-van den Hurk S., Gerdts V., Loehr B.I., Pontarollo R., Rankin R., Uwiera R., Babiuk L.A. Recent advances in the use of DNA vaccines for the treatment of diseases of farmed animals. Adv. Drug Deliv. Rev. 43:2000;13-28.
41. van Drunen Littel-van den Hurk S., Parker M.D., Massie B., van den Hurk J.V., Harland R., Babiuk L.A., Zamb T.J. Protection of cattle from BHV-1 infection by immunization with recombinant glycoprotein gIV. Vaccine. 11:1993;25-35.
42. van Drunen Littel-van den Hurk S., van den Hurk J.V., Babiuk L.A. Topographical analysis of bovine herpesvirus type-1 glycoproteins use of monoclonal antibodies to identify and characterize functional epitopes . Virology. 144:1985;216-227.
43. van Drunen Littel-van den Hurk S., van den Hurk J.V., Gilchrist J.E., Misra V., Babiuk L.A. Interactions of monoclonal antibodies and bovine herpesvirus type 1 (BHV-1) glycoproteins characterization of their biochemical and immunological properties . Virology. 135:1984;466-479.
44. Wang C., Sarnow P., Siddiqui A. Translation of human hepatitis C virus RNA in cultured cells is mediated by an internal ribosome-binding mechanism. J. Virol. 67:1993;3338-3344.
45. Wild J., Gruner B., Metzger K., Kuhrober A., Pudollek H.P., Hauser H., Schirmbeck R., Reimann J. Polyvalent vaccination against hepatitis B surface and core antigen using a dicistronic expression plasmid. Vaccine. 16:1998;353-360.